ABSTRACT: Structure−activity relationship exploration of the historical biarylurea series led to the identification of novel CNS penetrant CXCR2 antagonists with nanomolar potency, favorable PK profile and good developability potentials. More importantly, the key compound 22 showed efficacy in a cuprizone-induced demyelination model with twice daily oral administration, thereby supporting CXCR2 to be a potential therapeutic target for the treatment of demyelinating diseases such as multiple sclerosis.
A solution of 6-amino-3-chloro-2-[(4-methyl-1-piperazinyl)sulfonyl]phenol (212 mg, 0.693 mmol) and 2-chloro-1-fluoro-3-isocyanatobenzene (264 mg, 0.693 mmol) in DMF (10 mL) stirred at room temperature for 30 min. The reaction mixture was purified by Mass Directed Autopreparation to afford N-(2-chloro-3-fluorophenyl)-N'-{4-chloro-2-hydroxy-3- [(4-methyl-1-piperazinyl) 
N-{4-chloro-3-[(4-ethyl-1-piperazinyl)sulfonyl]-2-hydroxyphenyl}-N'-(2-chloro-3-fluorophenyl)urea (7)
Step1: 6-chloro-2-(1,1-dimethylethyl)-7-[(4-ethyl-1-piperazinyl)sulfonyl]-1,3-benzoxazole A solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-sulfonyl chloride (3 g, 9.73 mmol) and TEA (4.07 mL, 29.2 mmol) were diluted in THF (50 ml) under ice bath temperature was dropwise added 1-ethylpiperazine (1.112 g, 9.73 mmol) during 2 minutes. The reaction mixture was stirred at room temperature for 1h. The reaction mixture was concentrated then diluted with water and extracted with ethyl acetate (50 mL) for twice. The combined organic layers were dried over sodium sulfate, filtered, and concentrated. The resulting residue was purified by silica gel column eluting with 20% -33% ethyl acetate in petroleum ether to afford 6-chloro-2-(1,1-dimethylethyl)-7-[(4-ethyl-1-piperazinyl)sulfonyl]-1,3-benzoxazole (2.3 g, 5.48 mmol, 56.3 % yield) as brown viscous liquid. MS-ESI (m/z): MH + 386.2.
Step 2: 6-amino-3-chloro-2-{[4-(1-methylethyl)-1-piperazinyl]sulfonyl}phenol
A solution of 6-chloro-2-(1,1-dimethylethyl)-7-{[4-ethyl-1-piperazinyl]sulfonyl}-1,3-benzoxazole (2.30 g, 5.96 mmol) in 1,4-Dioxane (30 ml) and Water (6 ml) was added concentrated H 2 SO 4 (3.81 mL, 71.5 mmol). The reaction mixture was heated to 100 °C and stirred for overnight. After the solution was cooled to room temperature, The reaction mixture was evaporated in vacuo, then adjusted to pH=12 using 6M NaOH solution under ice bath temperature. The mixture was extracted with ethyl acetate (4 x ~50 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to obtain 6-amino-3-chloro-2-[(4-ethyl-1-piperazinyl)sulfonyl]phenol (1.6 g, 4.45 mmol, 74.7 % yield) as a brown oil. MS-ESI (m/z): MH + 320.1.
Step 3: N-{4-chloro-3-[(4-ethyl-1-piperazinyl)sulfonyl]-2-hydroxyphenyl}-N'-(2-chloro-3-fluorophenyl)urea
A solution of 6-amino-3-chloro-2-[(4-ethyl-1-piperazinyl)sulfonyl]phenol (120 mg, 0.375 mmol) and 2-chloro-1-fluoro-3-isocyanatobenzene (143 mg, 0.375 mmol in DMF (5 mL) stirred at room temperature for 30 min. The reaction mixture was purified by Mass Directed Autopreparation directly to afford the product N-{4-chloro-3-[(4-ethyl-1-piperazinyl)sulfonyl]-2-hydroxyphenyl}-N'-(2-chloro-3-fluorophenyl)urea (103 mg, 0.168 mmol, 44.9 % yield) as a white solid. 
N-(2-chloro-3-fluorophenyl)-N'-(4-chloro-2-hydroxy-3-{[4-(1-methylethyl)-1-piperazinyl]sulfonyl}phenyl)urea (8)
Step 1: 6-chloro-2-(1,1-dimethylethyl)-7-{[4-(1-methylethyl)-1-piperazinyl]sulfonyl}-1,3-benzoxazole A solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-sulfonyl chloride (3 g, 9.73 mmol) and triethylamine (4.07 mL, 29.2 mmol) were diluted in THF (50 ml) under ice bath temperature was dropwise added 1-(1-methylethyl)piperazine (1.248 g, 9.73 mmol) during 2 minutes. The reaction mixture was stirred at room temperature for 1h. The reaction mixture was concentrated then diluted with water and extracted with ethyl acetate (50 mL) for twice. The combined organic layers were dried over sodium sulfate, filtered, and concentrated. The resulting residue was purified by silica gel column eluting with 20% -33% ethyl acetate in petroleum ether to afford 6-chloro-2-(1,1-dimethylethyl)-7-[(4-(1-methylethyl)-1-piperazinyl)sulfonyl]-1,3-benzoxazole (2.7 g, 6.21 mmol, 63.8 % yield)
as brown viscous liquid. MS-ESI (m/z): MH + 400.2.
Step
2: 6-amino-3-chloro-2-{[4-(1-methylethyl)-1-piperazinyl]sulfonyl}phenol
A solution of 6-chloro-2-(1,1-dimethylethyl)-7-{[4-(1-methylethyl)-1-piperazinyl]sulfonyl}-1,3-benzoxazole (2.384 g, 5.96 mmol) in 1,4-Dioxane (30 ml) and Water (6 ml) was added concentrated H2SO4 (3.81 mL, 71.5 mmol). The reaction mixture was heated to 100 °C and stirred for overnight. After the solution was cooled to room temperature, The reaction mixture was evaporated in vacuo, then adjusted to pH=12 using 6M NaOH solution under ice bath temperature. The mixture was extracted with ethyl acetate (4 x ~50 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to obtain 6-amino-3-chloro-2-{[4-(1-methylethyl)-1-piperazinyl]sulfonyl}phenol (2 g, 5.45 mmol, 91 % yield) as a brown oil. MS-ESI (m/z): MH + 334.1.
Step 3: N-(2-chloro-3-fluorophenyl)-N'-(4-chloro-2-hydroxy-3-{[4-(1-methylethyl)-1-piperazinyl]sulfonyl}phenyl)urea
To a solution of 6-amino-3-chloro-2-{[4-(1-methylethyl)-1-piperazinyl]sulfonyl}phenol (100 mg, 0.300 mmol) in DMF (5 mL) was added 2-chloro-1-fluoro-3-isocyanatobenzene (114 mg, 0.300 mmol). The reaction mixture was stirred at room temperature for 30 min. The reaction mixture was purified by Mass Directed Autopreparation directly to afford N-(2-chloro-3-fluorophenyl)-N'-(4-chloro-2-hydroxy-3-{[4-(1-methylethyl)-1-piperazinyl]sulfonyl}phenyl)urea (66 mg, 0.101 mmol, 33.9 % yield) as a white solid. H NMR (DMSO-d 6 , 400 MHz) 1.21 (6 H, d, J=6.5 Hz), 3.49 (1 H, m), 7.09 (1 H, t, J=8.7 Hz), 7.21 (1 H, d, J=8.8 Hz), m), 7.94 (1 H, d, J=8.5 Hz), 8.28 (1 H, d, J=8.8 Hz), 9.28 (1 H, s), 9.37 (1 H, s). F (DMSO-d 6 , 376MHz): -73.6, -113.9. MS-ESI (m/z): MH + 505.1.
N-(4-chloro-3-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]sulfonyl}-2-hydroxyphenyl)-N'-(2-chloro-3-fluorophenyl)urea (9)
Step 1: 6-chloro-2-(1,1
-dimethylethyl)-7-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]sulfonyl}-1,3-benzoxazole
To a solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-sulfonyl chloride (2 g, 6.49 mmol) and triethylamine (2.71 mL, 19.47 mmol) in THF (20 mL) was added (2R, 6S)-2,6-dimethylmorpholine (0.747 g, 6.49 mmol). After stirring at room temperature for 2h, the reaction mixture was concentrated and poured into water (30 mL). The resulting solution was extracted with ethyl acetate (10 mL, three times). The combined organic layers was dried over sodium sulfate, filtered, and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography eluting with 20% ethyl acetate in hexane to afford 6-chloro-2-(1,1-dimethylethyl)-7-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]sulfonyl}-1,3-benzoxazole (1.8 g, 4.37 mmol, 67.4 % yield) as a white solid. MS-ESI (m/z): MH + 387.2.
Step 2: 6-amino-3-chloro-2-(((2S,6R)-2,6-dimethylmorpholino)sulfonyl)phenol
To a solution of 6-chloro-2-(1,1-dimethylethyl)-7-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]sulfonyl}-1,3-benzoxazole (1.8 g, 4.65 mmol) 1,4-Dioxane (20 ml) and Water (4 ml) was added concentrated H2SO4 (2.98 mL, 55.8 mmol). The reaction mixture was heated to 100 °C and stirred for overnight. After coolling to room temperature, the mixture was adjusted to pH=14 using 6 M NaOH. The resulting solution was extracted with ethyl acetate (3 x 50 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to obtain 6-amino-3-chloro-2-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]sulfonyl}phenol (1.5 g, 4.21 mmol, 90 % yield) as a brown oil.
MS-ESI (m/z): MH + 321.0.
Step 3:
To a solution of 6-amino-3-chloro-2-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]sulfonyl}phenol (100 mg, 0.312 mmol) and 2-chloro-1-fluoro-3-isocyanatobenzene (119 mg, 0.312 mmol) in DMF (5 mL) stirred at room temperature for 30 min. The reaction mixture was purified by Mass Directed Autopreparation directly to afford the product 
N-(4-chloro-3-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]sulfonyl}-2-hydroxyphenyl)-N'-(2,3-dichlorophenyl)urea (10)
To a solution of 6-amino-3-chloro-2-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]sulfonyl}phenol (100 mg, 0.312 mmol) and 1,2-dichloro-3-isocyanatobenzene (58.6 mg, 0.312 mmol) in DMF (5 mL) stirred at room temperature for 30 min. The reaction mixture was purified by Mass Directed Autopreparation directly to afford 
N-[4-chloro-3-(ethylsulfonyl)-2-hydroxyphenyl]-N'-(2,3-dichlorophenyl)urea (11)
Step 1: 6-chloro-2-(1,1-dimethylethyl)-7-(ethylthio)-1,3-benzoxazole
To a solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-thiol (5 g) in DMF (50 mL) was added bromoethane (4.51 g) and K 2 CO 3 (8.58 g). The mixture was stirred at rt overnight. Afterwards, the solvent was evaporated and the residue was treated with ethyl acetate (80mL). The resulting suspension was washed with water (2 x 80mL). The organic phase was dried over 
.
Step 2: 6-chloro-2-(1,1-dimethylethyl)-7-(ethylsulfonyl)-1,3-benzoxazole
To a solution of 6-chloro-2-(1,1-dimethylethyl)-7-(ethylthio)-1,3-benzoxazole (4.9 g) in dichloromethane (DCM) (80 mL) was added m-CPBA (9.40 g). The mixture was stirred at rt overnight. The reaction mixture was washed with saturated aqueous NaHCO 3 solution (2 x 80mL) and water (80mL). The organic phase was dried over anhydrous Na 2 SO 4 and then concentrated under vacuo to give the designed product 6-chloro-2-(1,1-dimethylethyl)-7-(ethylsulfonyl)-1,3-benzoxazole (4.5 g) as a white solid, which was used for the next step without further purification. MS(ES + ) m/z 302 (MH + ).
Step 3: 6-amino-3-chloro-2-(ethylsulfonyl)phenol
To a solution of 6-chloro-2-(1,1-dimethylethyl)-7-(ethylsulfonyl)-1,3-benzoxazole (4.5 g) in 1,4-dioxane (60 mL) and water (12.00 mL) was added H 2 SO 4 (4.77 mL) and the mixture was heated to 100°C for 48 h. The solvent was partially evaporated and the resulting solution was adjusted to PH=14 by addtion of 6N aqueous NaOH. The solution was then extracted with ethyl acetate (4*80mL) and the combined organic layers were dried over anhydrous Na 2 SO 4 and concentrated under vacuo to give the designed product 6-amino-3-chloro-2-(ethylsulfonyl)phenol (1.8 g).MS(ES + ) m/z236 (MH + ).
4: N-[4-chloro-3-(ethylsulfonyl)-2-hydroxyphenyl]-N'-(2,3-dichlorophenyl)urea
To a solution of 6-amino-3-chloro-2-(ethylsulfonyl)phenol (120 mg) in N,N-dimethylformamide (DMF) (10 mL) was added 1,2-dichloro-3-isocyanatobenzene (144 mg). 
N-(2-chloro-3-fluorophenyl)-N'-{4-chloro-2-hydroxy-3-[(1-methylethyl)sulfonyl]phenyl}urea (12)
Step 1: 6-chloro-2-(1,1-dimethylethyl)-7-[(1-methylethyl)thio]-1,3-benzoxazole
To a solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-thiol (1.1 g) and 2-bromopropane (0.641 mL) in N,N-Dimethylformamide (DMF) (25 mL) was added K 2 CO 3 (0.943 g). The reaction mixture was stirred at rt for 4 h. Afterwards, the solvent was evaporated and the residue was redissovled in EA (50mL 
Step 2: 6-chloro-2-(1,1-dimethylethyl)-7-[(1-methylethyl)sulfonyl]-1,3-benzoxazole
(DCM) (30 mL) was added m-CPBA (1.672 g). The solution was stirred at rt for 4 h. Afterwards, the solvent was evaporated and the residue was purified by column chroamtography to give the designed product
To solution of 6-chloro-2-(1,1-dimethylethyl)-7-[(1-methylethyl)sulfonyl]-1,3-benzoxazole (400 mg)in 1,4-dioxane (30 ml) and water (6ml) was added concentrated H 2 SO 4 (0.81 mL), the orange solution is heated to 110°C overnight. Reaction mixture was cooled to rt and treated with 6 M NaOH until pH=14 (pH paper). The mixture was extracted with ethyl acetate (3 x 150 mL). The combined organics were dried over sodium sulfate, filtered, and concentrated to give the designed product 6-amino-3-chloro-2-[(1-methylethyl)sulfonyl]phenol (160 mg), which was used without further purification. MS(ES + ) m/z 250 (MH + ).
Step 4 N,N-dimethylformamide (DMF) (10 mL) was added 2-chloro-1-fluoro-3-isocyanatobenzene (220 mg). The reaction mixture was stirred for 3 h. Afterwards, the solution was purified by Mass Directed Autopreparation to give the designed product -chloro-2-hydroxy-3-[(1-methylethyl) 
To a solution of 6-amino-3-chloro-2-[(1-methylethyl)sulfonyl]phenol (intermediate 6, 80 mg) in tetrahydrofuran (THF) (8 mL) was added 1,2-dichloro-3-isocyanatobenzene (0.043 mL) and 1,2-dichloro-3-isocyanatobenzene (0.043 mL). The reaction mixture was stirred for 4 h. Afterwards, the reaction mixture was purified by Mass Directed Autopreparation to give 
1-(3-(tert-butylsulfonyl)-4-chloro-2-hydroxyphenyl)-3-(2-chloro-3-fluorophenyl)urea (14)
Step 1 Step 2: 6-amino-2-(tert-butylsulfonyl)-3-chlorophenol
To a suspension of 2-(tert-butyl)-7-(tert-butylsulfonyl)-6-chlorobenzo[d]oxazole (10 g, 30.3 mmol) in 1,4-Dioxane (150 mL) and water (150 mL) was added HCl (61.4 mL, 606 mmol). The reaction mixture was refluxed for 5h. Then, the mixture was concentrated under reduced pressure to afford 6-amino-2-(tert-butylsulfonyl)-3-chlorophenol, hydrochloride (8 g, 26.6 mmol, 88 % yield), which used in the next step without purification. MS-ESI (m/z): MH + 264.1.
Step 3: 1-(3-(tert-butylsulfonyl)-4-chloro-2-hydroxyphenyl)-3-(2-chloro-3-fluorophenyl)urea
To a solution of 2-chloro-3-fluoroaniline (3.88 g, 26.6 mmol) in DCM (100 mL), was added triethylamine (11.14 mL, 80 mmol) and bis(trichloromethyl) carbonate (2.63 g, 8.87 mmol). The mixture was stirred at room temperature for 10 min to form solution 1. A solution of 6-amino-2-(tert-butylsulfonyl)-3-chlorophenol, hydrochloride (8 g, 26.6 mmol) in 1,4-Dioxane (100 mL) and water (10.00 mL) was added sodium bicarbonate (6.72 g, 80 mmol). After stirring at room temperature for 20 min, the fresh prepared solution 1 was added to the above solution. The resulting mixture was stirred for 30 min. The reaction mixture was partitioned between DCM (150 mL) and water (100 mL). The organic layer was washed with saturated brine, dried over sodium sulfate, and concentrated in vacuo. The resulting residue was purified by Mass Directed Autopreparation to afford 
N-[4-chloro-3-(cyclobutylsulfonyl)-2-hydroxyphenyl]-N'-(2-chloro-3-fluorophenyl)urea (15)
Step 1: 6-chloro-7-(cyclobutylthio)-2-(1,1-dimethylethyl)-1,3-benzoxazole
To a solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-thiol (5 g) in DMF (40 mL) was added bromocyclobutane (3.89 mL) and K 2 CO 3 (2.86 g). The reaction mixture was stirred at rt ovenight. Afterwards, the solvent was evaporated and the residue was treated with EA (80mL). The solution was washed by water (2 x 80ml) and the organic layer was then concentrated under vacuo to give the designed product 6-chloro-7-(cyclobutylthio)-2-(1,1-dimethylethyl)-1,3-benzoxazole (5.8 g). MS(ES+) m/z 296 (MH+).
Step 2: 6-chloro-7-(cyclobutylsulfonyl)-2-(1,1-dimethylethyl)-1,3-benzoxazole
To a solution of 6-chloro-7-(cyclobutylthio)-2-(1,1-dimethylethyl)-1,3-benzoxazole (5.8 g) in dichloromethane (DCM) (100 mL) was added m-CPBA (8.46 g). The reaction mixture was stirred at rt overnight. Afterwards, the solution was washed with saturated NaHCO 3 (3 x 80mL). The organic layer was then dried over anhydrous Na 2 SO 4 and concentrated under vacuo to
give the designed product 6-chloro-7-(cyclobutylsulfonyl)-2-(1,1-dimethylethyl)-1,3-benzoxazole (5.9 g), which was used without further purifaction. MS(ES + ) m/z 328 (MH + ).
Step 3: 6-amino-3-chloro-2-(cyclobutylsulfonyl)phenol
To a solution of 6-chloro-7-(cyclobutylsulfonyl)-2-(1,1-dimethylethyl)-1,3-benzoxazole (5.9 g) in 1,4-dioxane (60 mL) and water (12.00 mL) was added H 2 SO 4 (11.51 mL). The reaction mixture was heated at 110°C for 2 d. Afterwards, the solvent was partially removed and the residue was adjusted to pH 14. The resulting solution was extracted by EA (4 x 80mL). The combined organic layers was dried over anhydrous Na 2 SO 4 and concentrated under vacuo to give the designed product 6-amino-3-chloro-2-(cyclobutylsulfonyl)phenol (2.3 g), which was used without further purification. MS(ES Step 4: N-[4-chloro-3-(cyclobutylsulfonyl)-2-hydroxyphenyl]-N'-(2-chloro-3-fluorophenyl)urea
To a solution of 6-amino-3-chloro-2-(cyclobutylsulfonyl)phenol (intermediate 3, 140 mg) in N,N-dimethylformamide (DMF) (10 mL) was added 2-chloro-1-fluoro-3-isocyanatobenzene (184 mg). The reaction mixture was stirred at rt for 4 h.
Afterwards, the reaction mixture was purified by Mass Directed Autopreparation to give the designed product -(2-chloro-3-fluorophenyl) 
Step 1: 6-chloro-7-(cyclopentylthio)-2-(1,1-dimethylethyl)-1,3-benzoxazole
To a solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-thiol (5 g) in N,N-dimethylformamide (DMF) (40 mL) was added iodocyclopentane (4.78 mL) and K 2 CO 3 (8.58 g). The reaction mixture was stirred at rt overnight. Afterwards, the solvent was evaporated and the residue was dissolved in ethyl acetate (60mL). The resulting solution was washed with water (2 x 60mL). The organic phase was then concentrated to afford the designed product Step 2: 6-chloro-7-(cyclopentylsulfonyl)-2-(1,1-dimethylethyl)-1,3-benzoxazole
To a solution of 6-chloro-7-(cyclopentylthio)-2-(1,1-dimethylethyl)-1,3-benzoxazole (5.8 g) in dichloromethane (DCM) (100 mL) was added m-CPBA (1.615 g). The reaction mixture was stirred at rt overnight and washed with saturated NaHCO 3 (2 x 100mL) and then water (100mL). The organic phase was dried over anhydrous Na 2 SO 4 and then concentrated under vacuo to
give the crude product 6-chloro-7-(cyclopentylsulfonyl)-2-(1,1-dimethylethyl)-1,3-benzoxazole (5.5 g). The compound was used for the next step without further purification.
Step 3: 6-amino-3-chloro-2-(cyclopentylsulfonyl)phenol
To a solution of 6-chloro-7-(cyclopentylsulfonyl)-2-(1,1-dimethylethyl)-1,3-benzoxazole (5.5 g) in 1,4-dioxane (60 mL) and water (12.00 mL) was added H 2 SO 4 (10.29 mL). The reaction mixture was heated at 100°C for 48 h. Afterwards, the solvent was partially removed and the solution was adjusted to pH=14 by addition of 6N aqueous NaOH. The resulting solution was extracted with ethyl acetate (4x80mL) and the combined organic layers were dried over anhydrous Na 2 SO 4 and then concentrated under vacuo to give the product 6-amino-3-chloro-2-(cyclopentylsulfonyl)phenol (2.6 g).
4: N-[4-chloro-3-(cyclopentylsulfonyl)-2-hydroxyphenyl]-N'-(2-chloro-3-fluorophenyl)urea
To a solution of 6-amino-3-chloro-2-(cyclopentylsulfonyl)phenol (intermediate 1, 170 mg) in N,N-dimethylformamide (DMF) (10 mL) was added 2-chloro-1-fluoro-3-isocyanatobenzene (212 mg). The reaction mixture was stirred at rt for 4 h.
Afterwards, the solution was purified by Mass Directed Autopreparation to give the designed product 
N-[4-chloro-3-(cyclohexylsulfonyl)-2-hydroxyphenyl]-N'-(2-chloro-3-fluorophenyl)urea (17)
Step 1: 6-chloro-7-(cyclohexylthio)-2-(1,1-dimethylethyl)-1,3-benzoxazole A solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-thiol (1.2 g), bromocyclohexane (1.214 g), and K 2 CO 3
(1.372 g) was stirred at rt overnight. Afterwards, the solvent was evaporated and the residue was dissovled in EA (100mL). The resulting solution was washed with water (2 x 100mL). The organic layers was evaporated to give the crude product Step 2: 6-chloro-7-(cyclohexylsulfonyl)-2-(1,1-dimethylethyl)-1,3-benzoxazole
(40 mL) was added m-CPBA (1.039 g,). The reaction was stirred at rt overnight. Afterwards, the solvent was evaporated and the residue was purified by column chromatography to give the designed product
Step 3: 6-amino-3-chloro-2-(cyclohexylsulfonyl)phenol
and water (4.00 mL) was added H 2 SO 4 (1.977 mL). The reaction mixture was then heated to 100°C for 2 d. Afterwards, part of the solvent was evaporated and the remaining solution was adjusted to pH 14 by addition of 6N NaOH. The resulting solution was extracted with EA (5*50mL). The combined organic layers were dried over anhydrous Na 2 SO 4 and then concentrated under vacuo to give the designed product 6-amino-3-chloro-2-(cyclohexylsulfonyl)phenol (0.5 g), which was used without further
4: N-[4-chloro-3-(cyclohexylsulfonyl)-2-hydroxyphenyl]-N'-(2-chloro-3-fluorophenyl)urea
To a solution of 6-amino-3-chloro-2-(cyclohexylsulfonyl)phenol (50 mg) in DMF (8 mL) was added 2-chloro-1-fluoro-3-isocyanatobenzene (89 mg). The solution was stirred at room temperature for 4 h. Afterwards, the reaction mixture was purified by Mass Directed AutoPreparation to afford 
N-[4-chloro-2-hydroxy-3-(tetrahydro-3-furanylsulfonyl)phenyl]-N'-(2,3-dichlorophenyl)urea (18)
Step 1: tetrahydro-3-furanyl 4-methylbenzenesulfonate
To a solution of tetrahydro-3-furanol (2.7 g, 30.6 mmol) in DCM (60 mL) was added TsCl (6.43 g, 33.7 mmol) and triethylamine (8.54 mL, 61.3 mmol). The reaction mixture was stirred at room temperature overnight. Afterwards, the solution was washed with water (50mL, twice). The combined organic layers were dried over sodium sulfate, filtered and concentrated in vacuo to afford tetrahydro-3-furanyl 4-methylbenzenesulfonate (6.1 g, 25.2 mmol, 82 % yield) as a white solid without further purifiaction. MS-ESI (m/z): MH + 243.0.
Step 2: 2-(tert-butyl)-6-chloro-7-((tetrahydrofuran-3-yl)thio)benzo[d]oxazole
To a suspension of NaH (1.99 g, 49.6 mmol) in THF (50 mL) was added 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-thiol (4 g, 16.55 mmol). After stirring for 1 hour, tetrahydro-3-furanyl 4-methylbenzenesulfonate (4.01 g, 16.55 mmol) in THF was added to the above solution. The reaction mixture was heated to 80 °C and stirred overnight. The reaction mixture was cooled down to room temperature and quenched with saturated NaHCO 3 solution (50mL). The reaction mixture was extracted with DCM (50mL, twice). Combined organic layers were dried over soldium sulfate, filtered, and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography eluting with ethyl acetate in petroleum ether to give 6-chloro-2-(1,1-dimethylethyl)-7-(tetrahydro-3-furanylthio)-1,3-benzoxazole (3 g, 9.62 mmol, 58.1 % yield) as a white solid.
MS-ESI (m/z): MH + 270.0.
Step 3: 2-(tert-butyl)-6-chloro-7-((tetrahydrofuran-3-yl)sulfonyl)benzo[d]oxazole
To a solution of 6-chloro-2-(1,1-dimethylethyl)-7-(tetrahydro-3-furanylthio)-1,3-benzoxazole (3 g, 9.62 mmol) in DCM (60 mL) was added m-CPBA (1.743 g, 10.10 mmol). The reaction mixture was stirred overnight at room temperature.
Afterwards, the solvent was evaporated and the residue was purified by silica gel column chromatography eluting with 0-100% ethyl acetate in petroleum ether to give 6-chloro-2-(1,1-dimethylethyl)-7-(tetrahydro-3-furanylsulfonyl)-1,3-benzoxazole (2.6 g, 7.56 mmol, 79 % yield) as a white solid. MS-ESI (m/z): MH + 344.1.
Step 4: 6-amino-3-chloro-2-(tetrahydro-3-furanylsulfonyl)phenol
To a solution of 6-chloro-2-(1,1-dimethylethyl)-7-(tetrahydro-3-furanylsulfonyl)-1,3-benzoxazole (1.1 g, 3.20 mmol) in 1,4-Dioxane (30 mL) and Water (6.00 mL) was added H 2 SO 4 (2.046 mL, 38.4 mmol). The reaction mixture was heated to 100 °C and stirred for 2 days. After cooling to room termperature, the solution was concentrated to remove 1,4-dioxane and the remaining solution was adjusted to pH = 14 by addition of 6N NaOH. The solution was extracted by ethyl acetate (60 mL, three times) and the combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated to give the crude product 6-amino-3-chloro-2-(tetrahydro-3-furanylsulfonyl)phenol (380 mg, 1.368 mmol, 42.8 % yield) which was used without further purification. MS-ESI (m/z): MH + 278.1.
5: N-[4-chloro-2-hydroxy-3-(tetrahydro-3-furanylsulfonyl)phenyl]-N'-(2,3-dichlorophenyl)urea
A solution of 6-amino-3-chloro-2-(tetrahydro-3-furanylsulfonyl)phenol (120 mg, 0.432 mmol) and 1,2-dichloro-3-isocyanatobenzene (0.070 mL, 0.518 mmol) in DMF (10 mL) was stirred at room temperature for 4 h. The reaction mixture was directly purified by Mass Directed Autopreparation to give 
N-[4-chloro-2-hydroxy-3-(tetrahydro-2H-pyran-4-ylsulfonyl)phenyl]-N'-(2,3-dichlorophenyl)urea (19)
-dimethylethyl)-7-(tetrahydro-2H-pyran-4-ylthio)-1,3-benzoxazole
To a solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-thiol (3 g, 12.41 mmol) in DMF (35 mL) was added 4-bromotetrahydro-2H-pyran (2.048 g, 12.41 mmol) and K 2 CO 3 (3.43 g, 24.82 mmol). The reaction mixture was stirred at room temperature overnight. The reaction mixture was diluted with ethyl acetate (100 mL) and the solution was washed with saturated brine (60mL, three times). The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to give 6-chloro-2-(1,1-dimethylethyl)-7-(tetrahydro-2H-pyran-4-ylthio)-1,3-benzoxazole (3.2 g, 9.82 mmol, 79 % yield)
as a white solid. MS-ESI (m/z): MH + 326.1.
Step 2: 6-chloro-2-(1,1-dimethylethyl)-7-(tetrahydro-2H-pyran-4-ylsulfonyl)-1,3-benzoxazole
To a solution of 6-chloro-2-(1,1-dimethylethyl)-7-(tetrahydro-2H-pyran-4-ylthio)-1,3-benzoxazole (3.2 g, 9.82 mmol) in DCM (50 mL) was added m-CPBA (2.54 g, 14.73 mmol). The reaction mixture was stirred at room temperature overnight. The reaction mixture was quenched with saturated NaHCO 3 solution (30mL), and extracted with DCM (50mL, twice). The combined organic layers were dried over sodium sulfate, filtered and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography eluting with 0-100% ethyl acetate in petroleum ether to give 6-chloro-2-(1,1-dimethylethyl)-7-(tetrahydro-2H-pyran-4-ylsulfonyl)-1,3-benzoxazole (2.1 g, 5.87 mmol, 59.8 % yield).
MS-ESI (m/z): MH + 358.0.
Step 3: 6-amino-3-chloro-2-(tetrahydro-2H-pyran-4-ylsulfonyl)phenol
To a solution of 6-chloro-2-(1,1-dimethylethyl)-7-(tetrahydro-2H-pyran-4-ylsulfonyl)-1,3-benzoxazole (2.5 g, 6.99 mmol) in 1,4-Dioxane (40 mL) and Water (8.00 mL) was added H2SO4 (4.47 mL, 84 mmol). The reaction mixture was heated to 100 °C and stirred for 2 days. Afterwards, the solvent was partially evaporated and the residue was adjusted to pH 14 by the addition of 6N NaOH. The resulting solution was extracted by ethyl acetate (80mL, three times). The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentated in vacuo to give 6-amino-3-chloro-2-(tetrahydro-2H-pyran-4-ylsulfonyl)phenol (1.3 g, 4.46 mmol, 63.8 % yield) as a white solid without further purification. MS-ESI (m/z): [M+Na] + 292.0.
Step 4: N-[4-chloro-2-hydroxy-3-(tetrahydro-2H-pyran-4-ylsulfonyl)phenyl]-N'-(2,3-dichlorophenyl)urea
A solution of 6-amino-3-chloro-2-(tetrahydro-2H-pyran-4-ylsulfonyl)phenol (100 mg, 0.343 mmol) and 1,2-dichloro-3-isocyanatobenzene (0.055 mL, 0.411 mmol) in DMF (10 mL) was stirred at room temperature for 4h. The reaction mixture was directly purified by Mass Directed Autopreparation to give 
1-[4-chloro-2-hydroxy-3-(piperidine-4-sulfonyl)-phenyl]-3-(2,3-dichloro-phenyl)-urea (20)
Step 1 Step 2: 1,1-dimethylethyl 4-{[6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazol-7-yl]thio}-1-piperidinecarboxylate
To a solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-thiol (7000 mg, 29.0 mmol) and 1,1-dimethylethyl 4-[(methylsulfonyl)oxy]-1-piperidinecarboxylate (8089 mg, 29.0 mmol) in (30 mL) was added K 2 CO 3 (4031 mg, 29.0 mmol).
The resulting mixture was stirred at 80 °C overnight. The resulting mixture was partitioned bwtween ethyl acetate (150 mL) and water (50 mL). The organic layer was washed with saturated brine (100 mL), dried over sodium sulfate, and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography eluting with 0-10% ethyl acetate in petroleum Step 3: 1,1-dimethylethyl 4-{[6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazol-7-yl]sulfonyl}-1-piperidinecarboxylate
(11.8 g, 27.8 mmol) and 3-chlorobenzenecarboperoxoic acid (12.45 g, 55.5 mmol) in DCM (100 mL) was stirred at room temperature overnight. The mixure was added aq.NaHCO 3 and aq.Na 2 S 2 O 3 , after being stirred at room temperature for 30 min, it was extracted with DCM (2 x 150 mL), washed with brine and dried over sodium sulfate. Step 4: tert-butyl 4-((3-amino-6-chloro-2-hydroxyphenyl)sulfonyl)piperidine-1-carboxylate
To a solution of tert-butyl 4-((2-(tert-butyl)-6-chlorobenzo[d]oxazol-7-yl)sulfonyl)piperidine-1-carboxylate (65 g, 142 mmol) in 1,4-Dioxane (500 mL) and water (125 mL) was added H 2 SO 4 (60.7 mL, 1138 mmol). The resulting mixture was stirred at 100 °C overnight. The mixture was poured on ice and the solution was basified to pH=8 by treating with 2M NaOH solution. Then, to the mixture was added (BOC) 2 O (31.0 g, 142 mmol) dropwise, and the mixture was stirred at room temperature for 2 h. The mixture was partitioned between ethyl acetate (500 mL) and water (500 mL). The organic layer was washed with saturated brine (200 mL), dried over sodium sulfate, and concentrated in vacuo. The resulting residue was purified by silcia gel column chromatography eluting with 10-40% ethyl acetate in to afford tert-butyl 4-((3-amino-6-chloro-2-hydroxyphenyl)sulfonyl)piperidine-1-carboxylate (32 g, 82 mmol, 57.6 % yield) as a brown oil.
MS-ESI (m/z): [M+Na] + 412.9.
Step 5 Step 6 8, 128.5, 125.5, 124.7, 124.5, 123.3, 121.8, 121.3, 116.7, 57.5, 51.9, 42.9, 22 .2. MS-ESI (m/z): MH + 491.9.
1-(4-chloro-2-hydroxy-3-(1-methylpiperidin-4-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea (22)
Step 1: N-[4-chloro-2-hydroxy-3-(1-methyl-piperidine-4-sulfonyl)-phenyl]-2,2-dimethyl-propionamide A mixture of 4-(2-tert-butyl-6-chloro-benzooxazole-7-sulfonyl)-piperidine-1-carboxylic acid tert-butyl ester (4 g) in HCOOH/HCHO (10 mL, 2:3) was stirred at 100 0 C for 3h. Then the reaction was cooled to room temperature and was basified pH to 7-8 and extracted with EtOAc (3 x 400 mL). The organic layer was dried and concentrated. The residue was purified by silica gel column chromatography eluting with 0-2% MeOH in DCM to afford
g). MS (ES):
C 17 H 25 ClN 2 O 4 S requires 388; found 389 (M+H + ).
Step 2: 6-amino-3-chloro-2-(1-methyl-piperidine-4-sulfonyl)-phenol
mmol) in dioxane (21 mL) and H 2 SO 4 (42 mL, 30%) was stirred at reflux overnight. Then the mixture was cooled to room temperature and was basified pH to 7. The resulting mixture was extracted with EtOAc (3 x 400 mL). The combined organic layer was dried over sodium sulfate and concentrated to afford 6-amino-3-chloro-2-(1-methyl-piperidine-4-sulfonyl)-phenol (1.9 g) , which was used for next step without further purification. MS (ES): C 12 H 17 ClN 2 O 3 S requires 304; found 305 (M+H + ).
Step 3: 1-(4-chloro-2-hydroxy-3-(1-methylpiperidin-4-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea A solution of 6-amino-3-chloro-2-((1-methylpiperidin-4-yl)sulfonyl)phenol (14.5 g, 47.6 mmol) and 2-chloro-1-fluoro-3-isocyanatobenzene (6.12 g, 35.7 mmol) in DCM (10mL) was stirred at 25 °C for 18 h. The mixture was adjusted pH to 7~8, partitioned between ethyl (400 mL) and water (200 mL). The organic layer was dried over sodium sulfate, and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography eluting 0-5% MeOH in DCM to afford 1-(4-chloro-2-hydroxy-3-((1-methylpiperidin-4-yl)sulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea (11.0 g, 3, 156.9, 152.7, 149.8, 138.1, 129.8, 128.6, 128.5, 125.4, 124.5, 123.1, 118.0, 116.7, 57.5, 51.8, 42.9, 22 
1-(4-chloro-3-((1-ethylpiperidin-4-yl)sulfonyl)-2-hydroxyphenyl)-3-(2-chloro-3-fluorophenyl)urea (23)
Step 1: tert-butyl 4-((6-chloro-3-(3-(2-chloro-3-fluorophenyl)ureido)-2-hydroxyphenyl)sulfonyl)piperidine-1-carboxylate A mixture of tert-butyl 4-((3-amino-6-chloro-2-hydroxyphenyl)sulfonyl)piperidine-1-carboxylate (0.5 g, 1.279 mmol) and 2-chloro-1-fluoro-3-isocyanatobenzene (0.219 g, 1.279 mmol) in DCM (15 mL) was stirred at room temperature overnight. The mixture was concentrated and purified by silica gel column chromatography eluting with 10-30% ethyl acetate in petroleum ether to afford tert-butyl 4-((6-chloro-3-(3-(2-chloro-3-fluorophenyl)ureido)-2-hydroxyphenyl)sulfonyl)piperidine-1-carboxylate (0.5 g , 0.89 mmol,
% yield). MS-ESI (m/z): [M+Na]
+ 583.9.
Step 2: 1-(4-chloro-2-hydroxy-3-(piperidin-4-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea
To a solution of tert-butyl 4-((6-chloro-3-(3-(2-chloro-3-fluorophenyl)ureido)-2-hydroxyphenyl)sulfonyl)piperidine-1-carboxylate (0.5 g, 0.89 mmol) in DCM (15 mL) was added CF 3 COOH (0.685 mL, 8.89 mmol). The reaction mixture was stirred at room temperature overnight.
Then, the mixture was concentrated to afford 1-(4-chloro-2-hydroxy-3-(piperidin-4-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea (0.5 g) as a white solid. MS-ESI (m/z): MH + 462.1.
Step 3: 1-(4-chloro-3-((1-ethylpiperidin-4-yl)sulfonyl)-2-hydroxyphenyl)-3-(2-chloro-3-fluorophenyl)urea
To a solution of 1-(4-chloro-2-hydroxy-3-(piperidin-4-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea (500 mg, 1.081 mmol) in DMF (5 mL), was added acetaldehyde (0.607 mL, 10.81 mmol), AcOH (272 mg, 4.33 mmol) and NaBH3CN (64.9 mg, 1.081 mmol) at 0 °C, and the mixture was stirred for 10 min. The reaction was quenched with aq.NaHCO3, and then the mixture was extracted with EA (2×30 mL). The organic layer was dried over Na 2 SO 4 and concentrated in vacuo. 
(S)-1-(4-chloro-2-hydroxy-3-((1-methylpyrrolidin-3-yl)sulfonyl)phenyl)-3-(2,3-dichlorophenyl)urea (24)
Step 1: 1,1-dimethylethyl
(3S)-3-{[6-chloro-3-({[(2,3-dichlorophenyl)amino]carbonyl}amino)-2-hydroxyphenyl]sulfonyl}-1-pyrrolidinecarboxylate
To a solution of 1,1-dimethylethyl (3S)-3-[(3-amino-6-chloro-2-hydroxyphenyl)sulfonyl]-1-pyrrolidinecarboxylate (500 mg, 1.327 mmol) in N,N-Dimethylformamide (DMF) (10 mL) was added 1,2-dichloro-3-isocyanatobenzene (249 mg, 1.327 mmol).
The resulted mixture was stirred at 20 °C overnight. The residue was concentrated and purified by column chromatography to afford 1,1-dimethylethyl
(750 mg), which was used for next step without further purification. MS (ES): C 22 H 24 Cl 3 N 3 O 6 S requires 563; found 586 (M+Na + ).
2: N-{4-chloro-2-hydroxy-3-[(3S)-3-pyrrolidinylsulfonyl]phenyl}-N'-(2,3-dichlorophenyl)urea
To a solution of 1,1-dimethylethyl Step
3: (S)-1-(4-chloro-2-hydroxy-3-((1-methylpyrrolidin-3-yl)sulfonyl)phenyl)-3-(2,3-dichlorophenyl)urea
To a solution of N-{4-chloro-2-hydroxy-3-[(3S)-3-pyrrolidinylsulfonyl]phenyl}-N'-(2,3-dichlorophenyl)urea (50 mg, 0.108 mmol) in DMF (2 mL) was added formaldehyde solution (0.088 mL, 1.076 mmol) and AcOH (6.46 mg, 0.108 mmol).
After stirring at room temperature for 10 min. The mixture was added NaBH 3 CN (27.0 mg, 0.430 mmol) and was stirred for additional 5 min. Then the mixture was partitioned between ethyl acetate (15 mL) and saturated NaHCO 3 solution (10 mL) .
The organic layer was washed with saturated brine, and dried over sodium sulfate and concentrated in vacuo. 
N-(2-chloro-3-fluorophenyl)-N'-(4-chloro-2-hydroxy-3-{[(3S)-1-methyl-3-pyrrolidinyl]sulfonyl}phenyl)urea (25)

Step1: 1,1-dimethylethyl (3S)-3-{[6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazol-7-yl]thio}-1-pyrrolidinecarboxylate
To a solution of 6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazole-7-thiol (2369 mg, 9.80 mmol) and 1,1-dimethylethyl (3S)-3-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate (2600 mg, 9.80 mmol) in DMF (30 mL) was added Cs 2 CO 3 (6406 mg, 19.60 mmol). The reaction mixture was stirred at 50 °C overnight. After cooling, the reaction mixture was diluted with water (50 mL),extracted with EA (2 x 50 mL),washed and driedover sodium sulphate. The organic layers were concentrated to afford Step
3: 1,1-dimethylethyl (3S)-3-[(3-amino-6-chloro-2-hydroxyphenyl)sulfonyl]-1-pyrrolidinecarboxylate
To a solution of 1,1-dimethylethyl (3S)-3-{[6-chloro-2-(1,1-dimethylethyl)-1,3-benzoxazol-7-yl]sulfonyl}-1-pyrrolidinecarboxylate (1800 mg, 4.06 mmol) in dioxane (20 mL) and Water (4.00 mL) was added sulfuric acid (2.166 mL, 40.6 mmol). The resulted solution was heated at Boc 2 O (0.74 g, 3.39 mmol) at 0 o C, and stirred at 0 o C for 1 hour. The residue was seperated, and the aqueous layer was extracted with EA (2 x 50 mL). The combined organic layers were dried over sodium sulphate and concentrated to afford 1,1-dimethylethyl (3S)-3-[(3-amino-6-chloro-2-hydroxyphenyl)sulfonyl]-1-pyrrolidinecarboxylate (1.0 g), which was used for next step without further purification.MS (ES): C 15 H 21 ClN 2 O 5 S requires 376; found 377 (M+H + ).
Step 4 Step
5: N-(2-chloro-3-fluorophenyl)-N'-{4-chloro-2-hydroxy-3-[(3S)-3-pyrrolidinylsulfonyl]phenyl}urea
A mixture of 1,1-dimethylethyl
(500 mg, 0.912 mmol) and CF 3 COOH (0.675 mL, 9.12 mmol) in DCM (15 mL) was stirred at room temperature overnight. The Step 6 
(S)-1-(4-chloro-2-hydroxy-3-((1-methylazepan-4-yl)sulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea (26)
Step 1 Step
2: (S)-tert-butyl 4-((2-(tert-butyl)-6-chlorobenzo[d]oxazol-7-yl)thio)azepane-1-carboxylate
To a solution of (R)-tert-butyl 4-( (methylsulfonyl) Step 3 Step
4: (S)-tert-butyl 4-((3-amino-6-chloro-2-hydroxyphenyl)sulfonyl)azepane-1-carboxylate
To a solution of (S)-tert-butyl 4-((2-(tert-butyl)-6-chlorobenzo[d]oxazol-7-yl)sulfonyl) azepane-1-carboxylate (600 mg, 1.27 mmol) in 1,4-Dioxane (20 mL)/Water (5.00 mL) was added H 2 SO 4 (0.543 mL, 10.19 mmol). The reaction mixture was stirred at 100 °C overnight and for another 1 day. Then the reaction was cooled and basified with 2M NaOH to pH=8. To the mixture was added Boc 2 O (0.296 mL, 1.274 mmol). The resulting mixture was stirred at room temperature for 2 hours and then poured into water (50 mL), extracted with EA (50 mL*2), washed and dried over anhydrous sodium sulfate. The organic layer was concentrated to afford (S)-tert-butyl 4-((3-amino-6-chloro-2-hydroxyphenyl)sulfonyl)azepane-1-carboxylate (400 mg), which was used for next step without further purification. MS (ES): C 17 H 25 ClN 2 O 5 S requires 404; found 405 (M+H + ).
5: (S)-tert-butyl 4-((6-chloro-3-(3-(2-chloro-3-fluorophenyl)ureido)-2-hydroxy phenyl)sulfonyl)azepane-1-carboxylate
To a solution of 2-chloro-3-fluoroaniline (0.120 mL, 0.988 mmol) in DCM (20 mL), was added triethylamine (0.413 mL, Step 6 Step 7 Step 1: tert-butyl 6-((methylsulfonyl)oxy)-2-azaspiro[3.3]heptane-2-carboxylate
To a solution of tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate (1.3 g, 6.10 mmol in DCM (20 mL) was added triethylamine (1.7 mL, 12.19 mmol) and MsCl (0.57 mL, 7.31 mmol). The reaction mixture was stirred at 0 °C for 30 min.
Then, the mixture was partitioned between DCM (50 mL) and saturated NaHCO 3 solution (50 mL). The organic layer was washed with saturated brine, dried over sodium sulfate and concentrated in vacuo to afford tert-butyl 6-((methylsulfonyl)oxy)-2-azaspiro[3.3]heptane-2-carboxylate (1.7 g, 5.83 mmol, 96 % yield) as a white solid.
MS-ESI (m/z): [M+Na]
+ 314.0
Step 2: tert-butyl 6-((2-(tert-butyl)-6-chlorobenzo[d]oxazol-7-yl)thio)-2-azaspiro[3.3]heptane-2-carboxylate
To a solution of tert-butyl 6-((methylsulfonyl)oxy)-2-azaspiro[3.3]heptane-2-carboxylate (1.7 g, 5.83 mmol) in DMF (50 mL) was added 2-(tert-butyl)-6-chlorobenzo[d]oxazole-7-thiol (1.151 mL, 7.00 mmol) and potassium carbonate (1.61 g, 11.67 mmol). The reaction mixture was stirred at 100 °C overnight. After cooling to room temperature, the reaction mixture was partitioned between ethyl acetate (100 mL) and water (100 mL). The organic layer was washed with saturated brine (100 mL), dried over sodium sulfate and concentrated in vacuo. The resuting residue was purified by silica gel column chromatography eluting with 10-30% ethyl acetate in perotroleum ether to afford tert-butyl 6-( (2 Step 3 between DCM (100 mL) and saturated NaHCO 3 (50 mL). The organic layer was washed with saturated brine (50 mL), dried over sodium sulfate, and concentrated in vacuo. The resulting residue purified by silica gel column chromatography eluting with 10-30% ethyl acetate in petroleum ether to afford tert-butyl Step 4 and sodium triacetoxyborohydride (219 mg, 1.035 mmol). The resulting mixture was stirred at 0 °C for 1h. Then, the mixture was patitioned between ethyl acetate(50 mL) and saturated NaHCO 3 (50 mL). The organic layer was washed with saturated brine (50 mL), dried over sodium sulfate, and concentrated in vacuo to afford 2-(tert-butyl)-6-chloro-7-((2-methyl-2-azaspiro Step 7: 1-(4-chloro-2-hydroxy-3-((2-methyl-2-azaspiro[3.3]heptan-6-yl)sulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea
To a solution of 6-amino-3-chloro-2-((2-methyl-2-azaspiro[3.3]heptan-6-yl)sulfonyl)phenol (500 mg, 1.578 mmol) and triethylamine (160 mg, 1.578 mmol) in DMF (10 mL) was added 2-chloro-1-fluoro-3-isocyanatobenzene (271 mg, 1.578 mmol).
The reaction mixture was stirred at room temperature for 1 h. The reaction mixture was directly purified by MDAP to afford 1-(4-chloro-2-hydroxy-3-((2-methyl-2-azaspiro[3.3]heptan-6-yl)sulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea, 
1-(4-chloro-2-hydroxy-3-((7-methyl-7-azaspiro[3.5]nonan-2-yl)sulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea (28)
Step 1 Step 2 Step 3 Step 4 Step 5 Step 6: 6-amino-3-chloro-2-((7-methyl-7-azaspiro[3.5]nonan-2-yl)sulfonyl)phenol
To a solution of 2-(tert-butyl)-6-chloro-7-((7-methyl-7-azaspiro Step 7 m), 7.21 (1 H, d, J=8.8 Hz), 7.35 (1 H, td, J=8.3, 6.5 Hz), 7.96 (1 H, d, J=8.5 Hz), 8.33 (1 H, d, J=8.8 Step 1: tert-butyl 9-((methylsulfonyl)oxy)- Step 2 Step 4 Step 5 Step 7:
1-(4-chloro-2-hydroxy-3-((3-methyl-3-azaspiro[5.5]undecan-9-yl)sulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea
To a solution of 6-amino-3-chloro-2-((3-methyl-3-azaspiro[5.5]undecan-9-yl)sulfonyl)phenol, 2 hydrochloride (0.5 g, 1.121 mmol) in 1,4-Dioxane (10 mL) and water (1.0 mL) was added sodium bicarbonate (0.283 g, 3.36 mmol). After stirring at room temperature for 30 min, 2-chloro-1-fluoro-3-isocyanatobenzene (0.192 g, 1.121 mmol) was added to the above solution.
The resulting mixture was stirred at room temperature for another 30 min. Then, the solution was diluted with water (20 mL), extracted with ethyl acetate (50 mL, twice). The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The resulting residue was purified by Mass Directed Autopreparation to afford 1-(4-chloro-2-hydroxy-3-((3-methyl-3-azaspiro[5.5]undecan-9-yl)sulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea, 
N-(2-chloro-3-fluorophenyl)-N'-[4-chloro-2-hydroxy-3-(1-pyrrolidinylcarbonyl)phenyl]urea (30)
Step 1: 2-chloro-6-hydroxybenzonitrile
To a solution of 2-chloro-6-fluorobenzonitrile (12 g, 77 mmol) and sodium hydride (8.54 g, 231 mmol) in THF (150 mL) was added a solution of 2-(methylsulfonyl)ethanol (12.45 g, 100 mmol) in THF (150 mL). The reaction mixture was stirred at room temperature for 30 min. The reaction mixture was quenched with 2M HCl (50 mL) at 0 o C and partitioned between ethyl acetate (100 mL) and water (100 mL). The organic layer was washed with saturated brine, dried over sodium sulfate, and concentrated to give 2-chloro-6-hydroxybenzonitrile (11.8 g, 77 mmol, 100% yield) as a gray solid. MS-ESI (m/z): MH + 154.0.
Step 2: 6-chloro-2-hydroxy-3-nitrobenzonitrile 2-chloro-6-hydroxybenzonitrile (5 g, 32.6 mmol) was dissolved in nitric acid (40 ml, 895 mmol) at room temperature. The suspension mixture was allowed to warm to 30 o C and stirred until the solution turned clear. After cooling to room temperature, the mixture was poured into ice, partitioned between ethyl acetate (100 mL) and saturated brine (100 mL). The organic layer was dried over sodium sulfate, filtered and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography eluting with 0-100% ethyl acetate in petroleum ether to give 6-chloro-2-hydroxy-3-nitrobenzonitrile (6.0 g, 30.2 mmol, 30.9 % yield) as a white solid.
Step 3: 6-chloro-2-hydroxy-3-nitrobenzamide 6-chloro-2-hydroxy-3-nitrobenzonitrile (5g, 25.2 mmol) was dissolved in H 2 SO 4 (10 mL, 188 mmol) at room temperature.
The mixture was heated to 70 o C and stirred for 6h. The reaction mixture was poured into ice and partitioned between ethyl acetate (200 mL) and water (100 mL). The organic layer was washed with saturated brine (100 mL), dried over sodium sulfate, and concentrated to give 6-chloro-2-hydroxy-3-nitrobenzamide (4.36 g, 20.14 mmol, 80 % yield) as brown solid. MS-ESI (m/z):
Step 4: 6-chloro-2-hydroxy-3-nitrobenzoic acid
To a solution of 6-chloro-2-hydroxy-3-nitrobenzamide (1g, 4.62 mmol) in 80% of H 2 SO 4 (8mL, 120 mmol) at 10~15 o C was added slowly beneath the surface of the liquid a solution of sodium nitrite (1.3 mL, 13.00 mmol). The reaction was heated to 100 o C and stirred for 50 min. After cooling to room temperature, the mixture was partitioned between ethyl acetate (50 mL) and saturated brine (50 mL). The organic layer was dried over sodium sulfate, concentrated in vacuo to give 6-chloro-2-hydroxy-3-nitrobenzoic acid (942 mg, 3.90 mmol, 84 % yield) as a brown solid, which was directly used for next step without further purification.
Step 5: 3-chloro-6-nitro-2-(1-pyrrolidinylcarbonyl)phenol
To a solution of 6-chloro-2-hydroxy-3-nitrobenzoic acid (900 mg, 4.14 mmol and catalytic DMF (3.20 µL, 0.041 mmol) in dry DCM (20 mL) at 0 o C was added oxalyl chloride (0.72 mL, 8.27 mmol). The mixture was gradually warmed to room temperature and stirred for 3h. The mixture was concentrated in vacuo and re-dissolved in THF (20 mL). To the above solution was added a solution of pyrrolidine (412 mg, 5.79 mmol) and triethylamine (1.15 mL, 8.27 mmol) in THF (20 mL) at 0 o C.
After stirring at room temperature overnight, the mixture was quenched with H 2 O (10 mL), and partitioned between ethyl acetate (50 mL) and saturated brine (50 mL). The organic layer was dried over sodium sulfate, concentrated in vacuo. The resulting residue was purified by silica gel column chromatography eluting with 0-100% ethyl acetate in petroleum ether to afford 3-chloro-6-nitro-2-(1-pyrrolidinylcarbonyl)phenol (900 mg, 3.33 mmol, 80 % yield) as a brown solid. MS-ESI (m/z): MH + 271.1.
Step 6: 6-amino-3-chloro-2-(1-pyrrolidinylcarbonyl)phenol
To a solution of 3-chloro-6-nitro-2-(1-pyrrolidinylcarbonyl)phenol (900 mg, 3.33 mmol) in Methanol (300 mL) at room temperature was added nickel (1.951 mg, 0.033 mmol). The reaction mixture was stirred at room temperature under hydrogen overnight. The mixture was filtered and the filtration was concentrated to give 6-amino-3-chloro-2-(1-pyrrolidinylcarbonyl)phenol (600 mg, 1.99 mmol, 60.0 % yield) as a black solid. MS-ESI (m/z): MH + 241.1.
Step 7 Step 1: 3-chloro-6-nitro-2-(1-pyrrolidinylcarbonyl)phenol
To a solution of 6-chloro-2-hydroxy-3-nitrobenzoic acid (900 mg, 4.14 mmol) and catalytic DMF (3.20 µL, 0.041 mmol) in dry DCM (20 mL) at 0 o C was added oxalyl chloride (0.72 mL, 8.27 mmol). The mixture was gradually warmed to room temperature and stirred for 3h. Then, the mixture was concentrated in vacuo and re-dissolved in THF (20 mL). To the above solution was dropwise added a solution of pyrrolidine (412 mg, 5.79 mmol) and triethylamine (1.15 mL, 8.27 mmol) in THF (20 mL) at 0 o C. The reaction mixture was warmed to room temperature and stirred overnight. The reaction mixture was quenched with H 2 O (10 mL), and partitioned between DCM (50 mL) and saturated brine (25 mL). The organic layer was dried over sodium sulfate and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography eluting with 0-100% ethyl acetate in petroleum ether to give 3-chloro-6-nitro-2-(1-pyrrolidinylcarbonyl)phenol (900 mg, 3.33 mmol, 80 % yield) as a brown solid. MS-ESI (m/z): MH+ 271.1.
Step 2: 6-amino-3-chloro-2-(1-piperidinylcarbonyl)phenol
To a solution of 3-chloro-6-nitro-2-(1-piperidinylcarbonyl)phenol (830 mg, 2.92 mmol) in Methanol (30 mL) was added nickel (1.71 mg, 0.029 mmol). The reaction mixture was stirred at room temperature under hydrogen overnight. Then, the mixture was filtered through a celite pad and the filtrate was concentrated in vacuo to give 6-amino-3-chloro-2-(1-piperidinylcarbonyl)phenol (660 mg, 2.59 mmol, 89 % yield) as a black solid. MS-ESI (m/z): MH + 255.1.
Step 3 
CXCR2 Tango Assay
The assay measures ligand-induced activation of the receptor CXCR2 in a stable cell line containing the recombinant human CXCR2 linked to a TEV protease site and a Gal4-VP16 transcription factor (Invitrogen). Ligand binding to the receptor results in the recruitment of arrestin proteins (tagged with protease) to the receptor and triggers the release of a tethered transcription factor. The transcription factor enters the nucleus and activates the transcription of the reporter gene. The ability of a compound to inhibit CXCR2 activation is indirectly assessed by measuring the reporter gene activity.
Cells were starved for 24 hours at 37º C, 5% CO 2 , harvested and resuspended in assay medium at a density ~200,000 cells/ml. All test compounds were dissolved in DMSO at a concentration of 10 mM and were prepared in 100% DMSO to 6435-6444) was added to wells in row 2, columns 2-10 as reference compound. Test compounds were added to wells in row 2, columns 13-21 and rows 3-15, columns 2-10/13-21 (row 1 and 16 were left empty and not used). Compounds in solution were added to the assay plate (Greiner 781090) using an Echo (Labcyte) concentration-response program (50nl/well). The cell-free, un-stimulated and positive control (SB-332235) were loaded with 50 nl/well pure DMSO to ensure that the DMSO concentration was constant across the plate for all assays. 50μl of the cell suspension without hCXCL1 (a CXCR2 ligand) was added to each well in columns 12 and 23 of the plate (~10,000 cells per well). 50μl of the cell suspension with 80 nM hCXCL1 was added to each well in columns 2-11/13-22 of the plate (~10,000 cells per well). 50μl of assay medium was added to each well in the cell-free controls (columns 1 and 24). The cells were incubated overnight at 37º C/5% CO 2 . 10 µl of 6× substrate mixture (LiveBLAzer™-FRET B/G substrate (CCF4-AM) Cat # K1096 from Invitrogen, Inc.) was added to each well using Bravo and the plates incubated at room temperature for 2h in the dark. The plate was finally read on EnVision using one excitation channel (409 nm) and two emission channels (460 nm and 530 nm).
